Structural insights into the cross-neutralization of SARS-CoV and SARS-CoV-2 by the human monoclonal antibody 47D11

The emergence of SARS-CoV-2 antibody escape mutations highlights the urgent need for broadly neutralizing therapeutics. We previously identified a human monoclonal antibody, 47D11, capable of cross-neutralizing SARS-CoV-2 and SARS-CoV and protecting against the associated respiratory disease in an a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fedry, Juliette, Hurdiss, Daniel L., Wang, Chunyan, Li, Wentao, Obal, Gonzalo, Drulyte, Ieva, Du, Wenjuan, Howes, Stuart C., van Kuppeveld, Frank J.M., Förster, Friedrich, Bosch, Berend-Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172134/
https://www.ncbi.nlm.nih.gov/pubmed/33958322
http://dx.doi.org/10.1126/sciadv.abf5632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172134/
https://www.ncbi.nlm.nih.gov/pubmed/33958322
http://dx.doi.org/10.1126/sciadv.abf5632

Ejemplares similares